{"title":"Kajian Enzim Fibrinolitik pada Mikroorganisme Asal Pangan Fermentasi Asia: Review","authors":"Fathma Syahbanu, Setyaning Pawestri","doi":"10.20961/jthp.v16i1.72623","DOIUrl":null,"url":null,"abstract":"Data collected by WHO in 2019 shows an estimated 17.9 million (equivalent to 32% of global death). The total number is due to cardiovascular disease, 85% were due to heart attacks and strokes. One of the basic pathophysiologies of stroke is atero-thromboembolic (thrombosis). The accumulation of clots formed by fibrin in blood vessels can inhibit several processes in the body system, such as blood flow, oxygen transportation, and transportation of nutritional and non-nutritional compounds needed. Fibrinolytic enzymes from food microbes have attracted attention for further research as thrombolytic agents. The Bacillus genus from fermented foods can produce strong fibrinolytic enzymes, such as Bacillus natto from natto (Japan), Bacillus subtilis KCK-7 from Chungkook-jang (Korea), Bacillus weihenstephanensis from shrimp paste (Vietnam), Bacillus amyloliquefaciens MH18B1 from Hawaijar (India), Rhizopus chinensis 12 from Chinese wine (China), and Bacillus pumillus and Bacillus subtilis K2 from fermented soybean food products such as tempe gembus, red oncom, and moromi (Indonesia). The high protein content in soybeans can be used as a medium for the growth of proteolytic and fibrinolytic microorganisms. Studies in Asia regarding fibrinolytic enzymes from fermented foods are still limited, even though the Asian region comprises many countries rich in fermented foods. This review is relevant to healthy food ingredients from local fermented foods. Recently, microbial fibrinolytic enzymes from fermented foods have received tremendous interest in the medical field. Many local fermented foods are a potential source of fibrin-degrading enzymes, which can be further developed to treat diseases like stroke and heart attack. This article aims to review microbial fibrinolytic enzymes from various fermented foods and their impact on health, especially thrombosis. This manuscript review uses the narrative review method. From the overall discussion, it can be concluded that fermented foods have properties as fibrinolytic agents.","PeriodicalId":31982,"journal":{"name":"Jurnal Teknologi Industri Hasil Pertanian","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jurnal Teknologi Industri Hasil Pertanian","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20961/jthp.v16i1.72623","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
世卫组织2019年收集的数据显示,估计有1790万人死亡(相当于全球死亡人数的32%)。总人数是由于心血管疾病,85%是由于心脏病发作和中风。中风的基本病理生理之一是血栓形成。纤维蛋白在血管中形成的凝块的积累可以抑制身体系统的几个过程,如血液流动、氧气运输以及所需的营养和非营养化合物的运输。从食品微生物中提取的纤溶酶作为溶栓剂已引起人们的广泛关注。发酵食品中的芽孢杆菌属可产生强纤维蛋白溶解酶,如来自日本纳豆的纳豆芽孢杆菌,来自韩国忠国酱的枯草芽孢杆菌kck7,来自越南虾膏的魏氏芽孢杆菌,来自印度夏威夷的解淀粉芽孢杆菌MH18B1,来自中国葡萄酒的中国根霉12,以及来自发酵大豆食品如tempe gembus, red oncom和moromi(印度尼西亚)的pumillus和枯草芽孢杆菌K2。大豆中蛋白质含量高,可作为蛋白水解和纤溶微生物生长的培养基。尽管亚洲地区包括许多富含发酵食品的国家,但亚洲对发酵食品中纤维蛋白溶酶的研究仍然有限。本文综述了本地发酵食品中健康食品成分的研究进展。近年来,发酵食品中的微生物纤维蛋白溶解酶在医学领域引起了极大的兴趣。许多当地发酵食品是纤维蛋白降解酶的潜在来源,可以进一步开发用于治疗中风和心脏病等疾病。本文旨在综述各种发酵食品中的微生物纤维蛋白溶解酶及其对健康的影响,特别是对血栓形成的影响。本文采用叙事审稿的方法。综上所述,发酵食品具有溶纤维蛋白的特性。
Kajian Enzim Fibrinolitik pada Mikroorganisme Asal Pangan Fermentasi Asia: Review
Data collected by WHO in 2019 shows an estimated 17.9 million (equivalent to 32% of global death). The total number is due to cardiovascular disease, 85% were due to heart attacks and strokes. One of the basic pathophysiologies of stroke is atero-thromboembolic (thrombosis). The accumulation of clots formed by fibrin in blood vessels can inhibit several processes in the body system, such as blood flow, oxygen transportation, and transportation of nutritional and non-nutritional compounds needed. Fibrinolytic enzymes from food microbes have attracted attention for further research as thrombolytic agents. The Bacillus genus from fermented foods can produce strong fibrinolytic enzymes, such as Bacillus natto from natto (Japan), Bacillus subtilis KCK-7 from Chungkook-jang (Korea), Bacillus weihenstephanensis from shrimp paste (Vietnam), Bacillus amyloliquefaciens MH18B1 from Hawaijar (India), Rhizopus chinensis 12 from Chinese wine (China), and Bacillus pumillus and Bacillus subtilis K2 from fermented soybean food products such as tempe gembus, red oncom, and moromi (Indonesia). The high protein content in soybeans can be used as a medium for the growth of proteolytic and fibrinolytic microorganisms. Studies in Asia regarding fibrinolytic enzymes from fermented foods are still limited, even though the Asian region comprises many countries rich in fermented foods. This review is relevant to healthy food ingredients from local fermented foods. Recently, microbial fibrinolytic enzymes from fermented foods have received tremendous interest in the medical field. Many local fermented foods are a potential source of fibrin-degrading enzymes, which can be further developed to treat diseases like stroke and heart attack. This article aims to review microbial fibrinolytic enzymes from various fermented foods and their impact on health, especially thrombosis. This manuscript review uses the narrative review method. From the overall discussion, it can be concluded that fermented foods have properties as fibrinolytic agents.